Cargando…

Modeling Test and Treatment Strategies for Presymptomatic Alzheimer Disease

OBJECTIVES: In this study, we developed a model of presymptomatic treatment of Alzheimer disease (AD) after a screening diagnostic evaluation and explored the circumstances required for an AD prevention treatment to produce aggregate net population benefit. METHODS: Monte Carlo simulation methods we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burke, James F., Langa, Kenneth M., Hayward, Rodney A., Albin, Roger L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256252/ https://www.ncbi.nlm.nih.gov/pubmed/25474698 http://dx.doi.org/10.1371/journal.pone.0114339

Ejemplares similares

Public Willingness to Undergo Presymptomatic Genetic Testing for Alzheimer's Disease
por: Alanazy, Mohammed H., et al.
Publicado: (2019)

Detection of presymptomatic Alzheimer's disease through breath biomarkers
por: Emam, Shadi, et al.
Publicado: (2020)

Neural compensation in presymptomatic hAPP mouse models of Alzheimer's disease
por: Ammassari-Teule, Martine
Publicado: (2020)

Reply: Implications of presymptomatic change in thalamus and caudate in Alzheimer’s disease
por: Ryan, Natalie S., et al.
Publicado: (2013)

Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer’s disease
por: Weston, Philip S. J., et al.
Publicado: (2019)

Saliva Testing Is Accurate for Early-Stage and Presymptomatic COVID-19
por: Johnson, Abigail J., et al.
Publicado: (2021)

Presymptomatic cortical thinning in familial Alzheimer disease: A longitudinal MRI study
por: Weston, Philip S.J., et al.
Publicado: (2016)

The relative efficiency of time-to-progression and continuous measures of cognition in presymptomatic Alzheimer's disease
por: Li, Dan, et al.
Publicado: (2019)

INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease
por: Meyer, Pierre-François, et al.
Publicado: (2019)

Plasma GFAP in presymptomatic and symptomatic familial Alzheimer’s disease: a longitudinal cohort study
por: O'Connor, Antoinette, et al.
Publicado: (2023)

Presymptomatic Treatment With Andrographolide Improves Brain Metabolic Markers and Cognitive Behavior in a Model of Early-Onset Alzheimer’s Disease
por: Cisternas, Pedro, et al.
Publicado: (2019)

Conformation-Dependent Oligomers in Cerebrospinal Fluid of Presymptomatic Familial Alzheimer's Disease Mutation Carriers
por: Ringman, John M., et al.
Publicado: (2012)

Magnetic resonance imaging evidence for presymptomatic change in thalamus and caudate in familial Alzheimer’s disease
por: Ryan, Natalie S., et al.
Publicado: (2013)

Phenotypic Alterations in Hippocampal NPY- and PV-Expressing Interneurons in a Presymptomatic Transgenic Mouse Model of Alzheimer’s Disease
por: Mahar, Ian, et al.
Publicado: (2017)

Successful Object Encoding Induces Increased Directed Connectivity in Presymptomatic Early-Onset Alzheimer’s Disease
por: Ochoa, John Fredy, et al.
Publicado: (2016)

Is the risk of Alzheimer’s disease and dementia declining?
por: Langa, Kenneth M
Publicado: (2015)

Alterations in Cerebrospinal Fluid Proteins in a Presymptomatic Primary Glioma Model
por: Whitin, John C., et al.
Publicado: (2012)

Accelerated long-term forgetting in presymptomatic autosomal dominant Alzheimer's disease: a cross-sectional study
por: Weston, Philip S J, et al.
Publicado: (2018)

Quantitative detection and staging of presymptomatic cognitive decline in familial Alzheimer’s disease: a retrospective cohort analysis
por: O’Connor, Antoinette, et al.
Publicado: (2020)

Measuring cortical mean diffusivity to assess early microstructural cortical change in presymptomatic familial Alzheimer’s disease
por: Weston, Philip S. J., et al.
Publicado: (2020)

Visual short-term memory impairments in presymptomatic familial Alzheimer's disease: A longitudinal observational study
por: Pavisic, Ivanna M., et al.
Publicado: (2021)

Defining the presymptomatic phase of frontotemporal dementia
por: Russell, Lucy L., et al.
Publicado: (2023)

Emotion recognition of morphed facial expressions in presymptomatic and symptomatic frontotemporal dementia, and Alzheimer’s dementia
por: Jiskoot, Lize C., et al.
Publicado: (2020)

Presymptomatic Risk Assessment for Chronic Non-Communicable Diseases
por: Padhukasahasram, Badri, et al.
Publicado: (2010)

Laser Evoked Potentials in Early and Presymptomatic Huntington's Disease
por: de Tommaso, Marina, et al.
Publicado: (2016)

Presymptomatic diagnosis of Fabry’s disease: a case report
por: Hasselbalch, Rasmus Bo, et al.
Publicado: (2016)

Presymptomatic type 1 diabetes and disease severity at onset
por: Schneider, Josephine, et al.
Publicado: (2023)

Good problems to have? Policy and societal implications of a disease-modifying therapy for presymptomatic late-onset Alzheimer’s disease
por: Angrist, Misha, et al.
Publicado: (2020)

Genetic counseling and presymptomatic testing programs for Machado-Joseph Disease: lessons from Brazil and Portugal
por: Schuler-Faccini, Lavínia, et al.
Publicado: (2014)

Disease-related cortical thinning in presymptomatic granulin mutation carriers
por: Borrego-Écija, Sergi, et al.
Publicado: (2020)

Can risk modelling improve treatment decisions in asymptomatic carotid stenosis?
por: Burke, James F., et al.
Publicado: (2019)

Presymptomatic studies in genetic frontotemporal dementia
por: Rohrer, J.D., et al.
Publicado: (2013)

New animal models of progressive neurodegeneration: tools for identifying targets in predictive diagnostics and presymptomatic treatment
por: Tasker, R. Andrew, et al.
Publicado: (2010)

Recommendations for presymptomatic genetic testing and management of individuals at risk for hereditary transthyretin amyloidosis
por: Obici, Laura, et al.
Publicado: (2016)

Hippocampal Proliferation Is Increased in Presymptomatic Parkinson's Disease and due to Microglia
por: Doorn, Karlijn J., et al.
Publicado: (2014)

Secondary Transmission of Coronavirus Disease from Presymptomatic Persons, China
por: Zhang, Weiwei, et al.
Publicado: (2020)

Metabolic profiling of presymptomatic Huntington’s disease sheep reveals novel biomarkers
por: Skene, Debra J., et al.
Publicado: (2017)

Expression of Phenotypic Astrocyte Marker Is Increased in a Transgenic Mouse Model of Alzheimer's Disease versus Age-Matched Controls: A Presymptomatic Stage Study
por: Doméné, Aurélie, et al.
Publicado: (2016)

Isoform-specific hyperactivation of calpain-2 occurs presymptomatically at the synapse in Alzheimer’s disease mice and correlates with memory deficits in human subjects
por: Ahmad, Faraz, et al.
Publicado: (2018)

Ventricular volume expansion in presymptomatic genetic frontotemporal dementia
por: Tavares, Tamara P., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lqulebqgb8df09u67el1qeek3n